NCT04484493View on ClinicalTrials.gov

Corticosteroid Nasal Spray in COVID-19 Anosmia

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 8, 2020

Primary Completion Date

October 25, 2020

Study Completion Date

November 3, 2020

Conditions
Covid19Anosmia
Interventions
DRUG

mometasone furoate nasal spray

dose of 2 puff in each nostril (100 µg once daily each nostril).

Trial Locations (1)

13512

Benha University Hospital, Faculty of Medicine, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT04484493 - Corticosteroid Nasal Spray in COVID-19 Anosmia | Biotech Hunter | Biotech Hunter